This Friday, Nov. 14th, from 9 am to 1:30 p.m., the Weill Department of Medicine will host its 10th annual Research Retreat Day.Organized by Dr. Myles Wolf, Chair, Dr. Kyu Rhee, Professor and Vice Chair of Research, and Dr. Gregory Sonnenberg, Professor and Associate Vice Chair of Research, this highly collaborative event will bring together a diverse range of established and emerging faculty, trainees, and experts in complementary fields to foster and expand the Department's research...
In a testament to its dedication to fostering a culture of collaboration and mentorship, the Weill Department of Medicine’s (WDOM) 9th annual Research Retreat Day attracted 200 faculty, residents, and postdoctoral trainees throughout its day-long schedule of lectures and poster presentations on Nov. 1, 2024. The conference is unique in its aim to promote engagement among faculty at various stages of their career through both structured Q&A sessions and informal discussions. Many of the...
Coming up on November 1 from 8:30 a.m. to 4:30 p.m., we will present our 9th Annual Research Retreat Day!Hosted by Dr. Myles Wolf, Chair, Dr. John Leonard & Dr. Steven Lipkin: Enjoy an all-day symposium featuring poster sessions and lectures with a keynote address at 3:30 p.m.in Uris titled “Integrated Inpatient and Outpatient Care for Socioeconomically Diverse Medicare Patients at Increased Risk of Hospitalization: Results from two Randomized Trials of the Comprehensive Care...
The Weill Department of Medicine’s 8th annual Research Retreat Day attracted an impressive 180 junior faculty, postdoctoral students, graduate students, and research technicians across the Weill Cornell Medicine community on Sept. 12, 2023. All gathered in Belfer Research Building—and on Zoom—to share groundbreaking research representing numerous divisions, including Pulmonary & Critical Care medicine, Hematology & Medical Oncology, Regenerative Medicine, Gastroenterology &...
The study is focused on whether doxycycline may slow the progression of emphysema (a type of chronic obstructive pulmonary disease), in people with well-controlled HIV who are current or former smokers.
Dr. Leonard and colleagues found that rituximab (Rituxan) plus lenalidomide (Revlimid) elicited superior progression-free survival for patients with relapsed/refractory indolent non-Hodgkin’s lymphoma.
The new award into REasons for Geographic and Racial Differences in Stroke – Myocardial Infarction (REGARDS-MI) will support both scientific aims and early-stage investigator training, with a focus on structural racism.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the U.S.
Dr. Artis and team continue to illuminate the role of ILC2s, a family of white blood cells, with a new discovery published in Nature that has resolved an ongoing controversy.
Dr. Prigerson and her team will be piloting several interventions targeted to end-stage cancer patients and their caregivers to promote better communication and informed decision-making about care options.
